| BCBS Highmark West Virginia | Erythropoiesis Stimulating Agents | 2026-05-01 |
| BCBS Highmark West Virginia | Obinutuzumab (Gazyva) | 2026-05-01 |
| BCBS Highmark West Virginia | Rituximab (Rituxan), Rituximab Biosimilars, and Rituximab and Hyaluronidase Human (Rituxan Hycela) | 2026-05-01 |
| BCBS Highmark West Virginia | Amivantamab and Hyaluronidase-lpuj (Rybrevant Faspro) | 2026-05-01 |
| UHC Commercial Medical & Drug | Bariatric Surgery – Commercial and Individual Exchange Medical Policy | 2026-05-01 |
| UHC Commercial Medical & Drug | Chemotherapy Observation or Inpatient Hospitalization – Commercial and Individual Exchange Medical Policy | 2026-05-01 |
| UHC Commercial Medical & Drug | Edaravone – Commercial Medical Benefit Drug Policy | 2026-05-01 |
| UHC Commercial Medical & Drug | Enteral Nutrition (Oral and Tube Feeding) – Commercial and Individual Exchange Medical Policy | 2026-05-01 |
| UHC Commercial Medical & Drug | Hyperbaric Oxygen Therapy and Topical Oxygen Therapy – Commercial and Individual Exchange Medical Policy | 2026-05-01 |
| UHC Commercial Medical & Drug | Implantable Loop Recorders and Wearable Heart Rhythm Monitors – Commercial and Individual Exchange Medical Policy | 2026-05-01 |